132 related articles for article (PubMed ID: 36497442)
1. Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
Bari A; Gerardi C; Allocati E; Puzzovivo A; De Sanctis V; Tucci A; Balzarotti M; Franceschetti S; Merli F; Guarini A; Gini G; Minoia C
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497442
[TBL] [Abstract][Full Text] [Related]
2. Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi.
Nassi L; De Sanctis V; Loseto G; Gerardi C; Allocati E; Ciavarella S; Minoia C; Guarini A; Bari A
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158787
[TBL] [Abstract][Full Text] [Related]
3. Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi.
Franceschetti S; Annunziata MA; Agostinelli G; Gerardi C; Allocati E; Minoia C; Guarini A
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298616
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Healthy Lifestyles on Late Sequelae in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors. A Systematic Review by the Fondazione Italiana Linfomi.
Minoia C; Gerardi C; Allocati E; Daniele A; De Sanctis V; Bari A; Guarini A
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201563
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN; Flowers MED; D'Souza A; Ehrhardt MJ; Langston A; Yared JA; Hayashi RJ; Daly A; Olsson RF; Inamoto Y; Malone AK; DeFilipp Z; Margossian SP; Warwick AB; Jaglowski S; Beitinjaneh A; Fung H; Kasow KA; Marks DI; Reynolds J; Stockerl-Goldstein K; Wirk B; Wood WA; Hamadani M; Satwani P
Cancer; 2018 Feb; 124(4):816-825. PubMed ID: 29125192
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-Up of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: Aims and Methodological Approach for Fondazione Italiana Linfomi Systematic Reviews.
Gerardi C; Allocati E; Minoia C; Guarini A; Banzi R
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34198635
[TBL] [Abstract][Full Text] [Related]
7. Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma.
Bellitti E; Masciopinto P; Musto P; Arcuti E; Mastracci L; Opinto G; Ciavarella S; Guarini A; Cazzato G; Specchia G; Maiorano E; Gaudio F; Ingravallo G
Curr Oncol; 2022 Aug; 29(9):6115-6124. PubMed ID: 36135049
[TBL] [Abstract][Full Text] [Related]
8. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma.
Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW
Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159
[TBL] [Abstract][Full Text] [Related]
9. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.
Iwaki N; Sato Y; Kurokawa T; Maeda Y; Ohno K; Takeuchi M; Takata K; Orita Y; Nakao S; Yoshino T
Med Mol Morphol; 2013 Sep; 46(3):172-6. PubMed ID: 23512149
[TBL] [Abstract][Full Text] [Related]
10. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
11. Late Cardiological Sequelae and Long-Term Monitoring in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi.
Oliva S; Puzzovivo A; Gerardi C; Allocati E; De Sanctis V; Minoia C; Skrypets T; Guarini A; Gini G
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008222
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes.
Shokrgozar N; Dehghani M; Golmoghaddam H; Moghadam M; Rezaei N; Moayed V; Arandi N
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e388-e397. PubMed ID: 35098660
[TBL] [Abstract][Full Text] [Related]
13. A case of composite classical and nodular lymphocyte predominant Hodgkin lymphoma with progression to diffuse large B-cell non-Hodgkin lymphoma: Diagnostic difficulty in fine-needle aspiration cytology.
Das DK; Sheikh ZA; Al-Shama'a MH; John B; Alawi AM; Junaid TA
Diagn Cytopathol; 2017 Mar; 45(3):262-266. PubMed ID: 27888658
[TBL] [Abstract][Full Text] [Related]
14. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
15. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
16. Composite lymphoma of cervical lymph nodes with classical Hodgkin lymphoma and diffuse large B cell lymphoma: a case report and literature review.
Wang J; Zhang R
Ann Palliat Med; 2020 Sep; 9(5):3651-3662. PubMed ID: 32921109
[TBL] [Abstract][Full Text] [Related]
17. Late Endocrine and Metabolic Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi.
Di Molfetta S; Daniele A; Gerardi C; Allocati E; Minoia C; Loseto G; Giorgino F; Guarini A; De Sanctis V
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326591
[TBL] [Abstract][Full Text] [Related]
18. Composite lymphoma with diffuse large B-cell lymphoma and classical Hodgkin lymphoma components: A case report and review of the literature.
Goyal G; Nguyen AH; Kendric K; Caponetti GC
Pathol Res Pract; 2016 Dec; 212(12):1179-1190. PubMed ID: 27887763
[TBL] [Abstract][Full Text] [Related]
19. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
20. Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma.
Makita S; Maeshima AM; Taniguchi H; Kitahara H; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Kobayashi Y; Tobinai K
Int J Hematol; 2016 Sep; 104(3):396-9. PubMed ID: 27169615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
